Literature DB >> 17416328

Outcomes in children with nasolacrimal duct obstruction: Significance of persistent symptoms while stents are in place.

Gabriela M Espinoza1, Gregg T Lueder.   

Abstract

To evaluate the correlation between persistent symptoms while stents are in place and final outcome in children with nasolacrimal duct obstruction (NLDO). A retrospective observational case series, with medical record review that included indications for surgery, surgical procedure, presence of symptoms while stents were in place, and final outcome after stent removal. Twenty-eight children with NLDO had nasolacrimal duct stents placed in 42 eyes. Twenty-one of the 42 eyes (50%) had minimal or no signs or symptoms of NLDO while stents were in place, and 18 of 21 (86%) were symptom-free after stent removal. Twenty-one of the 42 eyes (50%) remained symptomatic while stents were in place. Eleven of these 21 eyes (52%) had good outcomes after stent removal. Ten (48%) of these patients had persistent symptoms after stent removal requiring further treatment. The prognosis for a good outcome is excellent if symptoms of NLDO resolve while stents are in place. The prognosis is poorer if symptoms of NLDO persist, but more than half of such patients still have good outcomes. Careful counseling of parents regarding these outcomes should be performed before considering additional interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17416328     DOI: 10.1016/j.jaapos.2006.07.002

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  2 in total

1.  Prophylactic Intraoperative Nasolacrimal Duct Intubation in Surgical Treatment of Facial Fractures-Is There a Role?

Authors:  Ryan Liang Wei Teoh; Pei Yuan Fong; Elijah Zhengyang Cai; Yan Lin Yap; Eileen Chor Hoong Hing; Han Jing Lee; Vigneswaran Nallathamby; Wei Chen Ong; Jane Lim; Gangadhara Sundar; Thiam Chye Lim
Journal:  Arch Plast Surg       Date:  2022-04-06

Review 2.  Down syndrome: a review of ocular manifestations.

Authors:  Abid Haseeb; Elisah Huynh; Reem H ElSheikh; Ahmed S ElHawary; Christina Scelfo; Danielle M Ledoux; Daniel E Maidana; Abdelrahman M Elhusseiny
Journal:  Ther Adv Ophthalmol       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.